SYROS PHARMACEUTICALS, INC. Operating Lease Cost
SYROS PHARMACEUTICALS, INC. reported Operating Lease Cost of $772.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-05-14
- SYROS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2024-03-31 was $772.00K, a 0.00% change year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2023-12-31 was $772.00K, a 0.00% change year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2023-09-30 was $772.00K, a 0.00% change year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2023-06-30 was $772.00K, a 0.00% change year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, cost for fiscal 2023 was $3.09M, a 0.00% change from fiscal 2022.
- SYROS PHARMACEUTICALS, INC. operating lease, cost for fiscal 2022 was $3.09M, a 4.39% increase from fiscal 2021.
- SYROS PHARMACEUTICALS, INC. operating lease, cost for fiscal 2021 was $2.96M, a 3.43% decline from fiscal 2020.
- SYROS PHARMACEUTICALS, INC. operating lease, cost for fiscal 2020 was $3.06M, a 16.07% increase from fiscal 2019.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-03-31 | $772.00K 10-Q · filed 2024-05-14 | $1.54M derived: sum of 2 quarters · filed 2024-05-14 | $2.32M derived: sum of 3 quarters · filed 2024-05-14 | $3.09M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $772.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.54M derived: sum of 2 quarters · filed 2024-03-27 | $2.32M derived: sum of 3 quarters · filed 2024-03-27 | $3.09M 10-K · filed 2024-03-27 |
| 2023-09-30 | $772.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.54M derived: sum of 2 quarters · filed 2023-11-14 | $2.32M 10-Q · filed 2023-11-14 | $3.09M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.54M 10-Q · filed 2023-08-08 | $2.32M derived: sum of 3 quarters · filed 2023-08-08 | $3.09M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $772.00K 10-Q · filed 2023-05-10 | $1.54M derived: sum of 2 quarters · filed 2023-05-10 | $2.32M derived: sum of 3 quarters · filed 2023-05-10 | $3.09M derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | $772.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.54M derived: sum of 2 quarters · filed 2023-03-02 | $2.32M derived: sum of 3 quarters · filed 2023-03-02 | $3.09M 10-K · filed 2023-03-02 |
| 2022-09-30 | $772.00K 10-Q · filed 2022-11-14 | $1.54M derived: sum of 2 quarters · filed 2022-11-14 | $2.32M 10-Q · filed 2022-11-14 | $2.96M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.54M 10-Q · filed 2022-08-09 | $2.19M derived: sum of 3 quarters · filed 2022-08-09 | $2.96M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $772.00K 10-Q · filed 2022-05-16 | $1.41M derived: sum of 2 quarters · filed 2022-05-16 | $2.19M derived: sum of 3 quarters · filed 2022-05-16 | $2.96M derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.41M derived: sum of 2 quarters · filed 2022-03-15 | $2.19M derived: sum of 3 quarters · filed 2022-03-15 | $2.96M 10-K · filed 2022-03-15 |
| 2021-09-30 | $772.00K 10-Q · filed 2021-11-05 | $1.54M derived: sum of 2 quarters · filed 2021-11-05 | $2.32M 10-Q · filed 2021-11-05 | $3.19M derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-06-30 | $772.00K 10-Q · filed 2021-08-05 | $1.54M 10-Q · filed 2021-08-05 | $2.41M derived: sum of 3 quarters · filed 2021-08-05 | $3.15M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $772.00K 10-Q · filed 2021-05-06 | $1.64M derived: sum of 2 quarters · filed 2021-05-06 | $2.38M derived: sum of 3 quarters · filed 2021-05-06 | $3.12M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | $870.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.61M derived: sum of 2 quarters · filed 2021-03-04 | $2.35M derived: sum of 3 quarters · filed 2021-03-04 | $3.06M 10-K · filed 2021-03-04 |
| 2020-09-30 | $739.00K 10-Q · filed 2020-11-05 | $1.48M derived: sum of 2 quarters · filed 2020-11-05 | $2.19M 10-Q · filed 2020-11-05 | $2.55M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | $739.00K 10-Q · filed 2020-08-06 | $1.45M 10-Q · filed 2020-08-06 | $1.81M derived: sum of 3 quarters · filed 2020-08-06 | $2.77M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | $330.00K 10-Q · filed 2020-05-07 | $1.08M derived: sum of 2 quarters · filed 2020-05-07 | $2.04M derived: sum of 3 quarters · filed 2020-05-07 | $2.47M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $746.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $1.71M derived: sum of 2 quarters · filed 2020-03-05 | $2.14M derived: sum of 3 quarters · filed 2020-03-05 | $2.64M 10-K · filed 2020-03-05 |
| 2019-09-30 | $959.00K 10-Q · filed 2019-11-12 | $1.40M derived: sum of 2 quarters · filed 2019-11-12 | $1.89M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $437.00K 10-Q · filed 2019-08-01 | $490.00K 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $54.00K 10-Q · filed 2019-05-01 |